Southern Vitreoretinal Assoc
Tallahassee, Florida, United States
Ophthalmologist in Tallahassee, Florida
2439 Care Dr, Tallahassee, FL 32308
About Southern Vitreoretinal Assoc
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
16
Genentech, Inc.
2
Kodiak Sciences Inc
2
Allergan
1
Apellis Pharmaceuticals, Inc.
1
Bayer
1
IVERIC bio, Inc.
1
NGM Biopharmaceuticals, Inc
1
Clinical Trials at Southern Vitreoretinal Assoc
During the past decade, Southern Vitreoretinal Assoc conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 10 clinical trials were completed, i.e. on
average, 45.5% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 6 clinical trials were completed. i.e. 54.5%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Safety and Efficacy Study of Brimonidine Intravitreal Implant in Geographic Atrophy Secondary to Age-related Macular Degeneration
2014-05-09
2018-03-30
Terminated
310
A Study Investigating the Efficacy and Safety of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
2014-09-18
2018-01-29
Terminated
906
A Study Investigating the Safety and Efficacy of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
2014-10-06
2018-01-23
Terminated
975
A Proof-of-Concept Study of Faricimab (RO6867461) in Participants With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)
2015-08-11
2017-09-26
Completed
273
A Study of Faricimab (RO6867461) in Participants With Center-Involving Diabetic Macular Edema
2016-04-27
2017-12-14
Completed
229
Long-Term Safety of Lampalizumab Intravitreal (ITV) Injections in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (OMASPECT)
2016-07-21
2018-01-31
Terminated
994
Study to Evaluate Faricimab (RO6867461; RG7716) for Extended Durability in the Treatment of Neovascular Age Related Macular Degeneration
2017-01-27
2018-03-29
Completed
76
Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration
2018-08-31
2023-01-30
Active, not recruiting
600
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Southern Vitreoretinal Assoc" #1 sponsor was "Hoffmann-La Roche" with 16 trials, followed by "Genentech, Inc." with 2 trials
sponsored, "Kodiak Sciences Inc" with 2 trials sponsored, "Allergan" with 1 trials sponsored and "Apellis Pharmaceuticals, Inc."
with 1 trials sponsored. Other sponsors include -2 different institutions and
companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Southern Vitreoretinal Assoc"
#1 collaborator was "Chugai Pharmaceutical" with 1 trials as a collaborator and "Regeneron Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Southern Vitreoretinal Assoc
According to Clinical.Site data, the most researched conditions in "Southern Vitreoretinal Assoc" are
"Geographic Atrophy" (9 trials), "Diabetic Macular Edema" (5 trials), "Macular Degeneration" (3 trials), "Macular Degeneration, Age-Related" (3 trials) and "Neovascular Age-Related Macular Degeneration" (3 trials). Many other conditions were trialed in "Southern Vitreoretinal Assoc" in a lesser frequency.
Clinical Trials Intervention Types at Southern Vitreoretinal Assoc
Most popular intervention types in "Southern Vitreoretinal Assoc" are "Drug" (24 trials), "Other" (9 trials), "Procedure" (3 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Sham Procedure" (10 trials), "Faricimab" (8 trials), "Aflibercept" (5 trials), "Ranibizumab" (4 trials) and "Lampalizumab" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Southern Vitreoretinal Assoc
The vast majority of trials in "Southern Vitreoretinal Assoc" are
25 trials for "All" genders.
Clinical Trials Status at Southern Vitreoretinal Assoc
Currently, there are NaN active trials in "Southern Vitreoretinal Assoc".
undefined are not yet recruiting,
2 are recruiting,
10 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 7 completed trials in Southern Vitreoretinal Assoc,
undefined suspended trials,
and 6 terminated clinical trials to date.
Out of the total trials that were conducted in Southern Vitreoretinal Assoc, 1 "Phase 1"
clinical trials were conducted, 7 "Phase 2" clinical
trials and 17 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".